Recent publications
Publications can be found through the individual profile pages of the division's staff members.
View the complete overview of the publications in PubMed.
Most recent publications
2026
Timmerman, A., Rodenhuis, N., Crane-van Opstal, L. M. A., de Boer, A., Bongers, L., & Pasmooij, A. M. G. (2026). Factors influencing pharmaceutical companies’ decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands. Journal of Pharmaceutical Policy and Practice, 19(1), Article 2605391. https://doi.org/10.1080/20523211.2025.2605391
Trang, T. P. H., Bazelier, M. T., Klungel, O. H., Groenwold, R. H. H., Douglas, I. J., Schultze, A., & Bots, S. H. (2026). Negative controls for bias detection within exposure-anchored self-controlled designs: applications and considerations. International Journal of Epidemiology, 55(6), Article dyag231. https://doi.org/10.1093/ije/dyag231
Tillemans, M. P. H., Giezen, T. J., Egberts, T. C. G., & J. Kalisvaart, K. (2026). The association between medication use and vitamin B12 deficiency in the elderly population: a cross- sectional study. BMC Geriatrics, 26(1), Article 294. https://doi.org/10.1186/s12877-026-07040-6
Barjesteh van Waalwijk van Doorn-Khosrovani, S., & Leopold, C. (2026). When one trial is not enough: Lessons from darvadstrocel approval and withdrawal. Gastroenterology, 171(5), 984-985. https://doi.org/10.1053/j.gastro.2026.03.035
van den Hemel, R. B. L. J., Fiolet, A. T. L., Gamba, M. A., Souverein, P. C., Klungel, O. H., Bloem, L. T., & Bots, S. H. (2026). Comparative treatment effects of direct oral anticoagulants versus warfarin for nonvalvular atrial fibrillation in clinical practice vary over time due to channelling. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70898
Postma, D. J. (2026). Medicine shortages: from national signals to global supply chains and local patient impact. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/3808
Beravs Bervar, K., Goettsch, W., Gutierrez-Ibarluzea, I., Skali, A., Rűther, A., Lipska, I., & Turk, E. (2026). Authors' response to "Rethinking Slovenia's health technology assessment system". International Journal of Technology Assessment in Health Care, 42(1), e94. https://doi.org/10.1017/S0266462326104164
Brinkhuis, F., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., Narsai, K., Goettsch, W. G., & van den Ham, H. A. (2026). Comparing harmonization in medicines regulation and health technology assessment in Europe: lessons for the EU HTA regulation. International Journal of Technology Assessment in Health Care, 42(1), Article e91. https://doi.org/10.1017/S0266462326104267
Riera-Arnau, J., Abtahi, S., Sabaté Gallego, M., Ballarín, E., Gamba, M., Pajouheshnia, R., Hoxhaj, V., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., Sánchez-Sáez, F., Ientile, V., Ingrasciotta, Y., ... Durán, C. E. (2026). Switching Patterns of Oral Retinoids to Alternative Medications: An Interrupted Time-Series Analysis of Four European Countries. Drug Safety. Advance online publication. https://doi.org/10.1007/s40264-026-01738-7
van der Meer, P., van Veldhuisen, D. J., Voordes, G. H. D., Tijssen, J., Alings, M., Bouvy, M. L., Swart, H. P., Houtgraaf, H. J., Dorman, H. G. R., Rienstra, M., Damman, K., & Mosterd, A. (2026). Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial. European Heart Journal, 47(38), 5545-5553. https://doi.org/10.1093/eurheartj/ehag385
Ringeling, L. T., Gangapersad, R. N., Lieuw, L., Souverein, P. C., Heerdink, E. R., Garcia-Gomez, P., Hillegers, M. H. J., Koch, B. C. P., & Dierckx, B. (2026). Lithium-related adverse drug reactions in children: A case-control study comparing lithium to second-generation antipsychotics in VigiBase. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70827
Rijmers, J., Bui, V., Lebre, M. C., Schinkel, A. H., Beijnen, J. H., van Tellingen, O., & van Winden, L. J. (2026). Development and validation of an LC–MS/MS method for the quantification of the KRASG12C inhibitor divarasib. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1282, Article 125211. https://doi.org/10.1016/j.jchromb.2026.125211
van Paassen, J. G., Deneer, V. H. M., Kempen, T. G. H., & Bouvy, M. L. (2026). Access to clinical data for direct oral anticoagulant prescriptions in community pharmacy and implications for medication optimisation: a mixed-methods study. International Journal of Clinical Pharmacy, 48(5), 1871-1883. https://doi.org/10.1007/s11096-026-02159-3
van Rijt-Weetink, Y. R. J., Huisman, R. E., van Wieringen, J.-P., Crijns, H. J. M. J. I., van Hunsel, F. P. A. M., Passier, A. L. M., Borgsteede, S., Egberts, A. C. G. T., Yates, L. M., & van Puijenbroek, E. P. (2026). Characteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands-A contribution of the ConcePTION project. British Journal of Clinical Pharmacology, 92(10), 3365-3374. https://doi.org/10.1002/bcp.70615
De Mattia, E., Polesel, J., van der Lee, M., Bohringer, S., Gambron, M., Perfler, S., Roncato, R., Canil, G., Posocco, B., Cats, A., Mathijssen, R. H. J., Guchelaar, H. J., Schellens, J. H. M., Gelderblom, H., Spina, M., Puglisi, F., Swen, J. J., & Cecchin, E. (2026). DPYD c.85 T > C, DPYD c.496 A>G, and DPYD c.2194 G>A and severe toxicity to fluoropyrimidines in PREPARE and Alpe-DPD trials. An original study and meta-analysis. Pharmacological Research, 232, Article 108451. https://doi.org/10.1016/j.phrs.2026.108451
Siiskonen, S., Laine, S., Airla, N., Laaksonen, N., Lepola, P., Vesinurm, M., & Timonen, A. (2026). Multistakeholder collaboration to translate the ICH GCP E6(R3) guideline into Finnish: Supporting clinical trial conduct in Finland. Regulatory Rapporteur, 23(9). https://www.regulatoryrapporteur.org/clinical-trials/multistakeholder-collaboration-to-translate-the-ich-gcp-e6r3-guideline-into-finnish-supporting-clinical-trial-conduct-in-finland/1174.article
Bots, S. H., Schultze, A., Pajouheshnia, R., Douglas, I. J., Gini, R., Klungel, O. H., & Groenwold, R. H. H. (2026). Negative controls and how to use them: a guidance paper. International Journal of Epidemiology, 55(5), Article dyag163. https://doi.org/10.1093/ije/dyag163
van Royen, F. S., van Smeden, M., van Doorn, S., Souverein, P., van Amsterdam, W. A. C., Rutten, F. H., Sheppard, J. P., & Geersing, G.-J. (2026). Predicting deep venous thrombosis and pulmonary embolism in community patients with superficial venous thrombosis: a model development study. Journal of Thrombosis and Haemostasis, 24(10), 3637-3646. https://doi.org/10.1016/j.jtha.2026.06.036
Metselaar-Albers, M., Bloem, L., van Balen, D., Suijkerbuijk, K., & Lalmohamed, A. (2026). Proton pump inhibitors and durvalumab in PACIFIC. The Lancet Oncology, 27(10), e446-e446. Article e446. https://doi.org/10.1016/S1470-2045(26)00402-X
Wilpshaar, M. C., Hilarius, D., Prada, L., Weltermann, A., & Leopold, C. (2026). Repurposing Registries: Completeness of Real‐World Data for Regulatory and HTA Purposes in Three Cancer‐Focused Registries. Clinical Pharmacology & Therapeutics, 120(4), 943-954. https://doi.org/10.1002/cpt.70368
van Brussel, M., IJzer, J., Evers, C., Donker, S., van Harten, J., Geelen van, S., Jambroes, M., Jaremba, U., van Lambalgen, R., van Lent, L., van Miltenburg, N., Nordquist, R., Surma, H., Vijge, M., Wolthers, M., & van der Zijden, J. (2026). Tussen droom en daad. Van visie en filosofie tot concreet curriculum. Th&ma, 4, 70-74.
Gómez-Coronado-Martín, R., Chacón-García, A., López-de-Andrés, A., Salinero-Fort, M. A., Weir, D. L., & Burgos-Lunar, C. D. (2026). Validating Type 2 Diabetes Diagnoses Across the Madrid Hospital Network: Evidence for Secondary Use of the CMBD in the European Health Data Space. Journal of Clinical Medicine, 15(19), Article 7717. https://doi.org/10.3390/jcm15197717
de Jong, A. J., Bennink, D. S. A., Ehrenzeller, S., Speich, B., Briel, M., Ong, S. W. X., Pasmooij, A. M. G., & Hensgens, M. P. M. (2026). Clinical and regulatory acceptability of hierarchical composite endpoints in infectious disease clinical trials. Clinical Microbiology and Infection. Advance online publication. https://doi.org/10.1016/j.cmi.2026.09.018
Stoelinga, J., Hollak, C. E., Timmers, L., Goettsch, W. G., & Leopold, C. (2026). Health Technology Assessment Lifecycle Concepts: A Scoping Review Outlining the Change in Policies to Manage Uncertainties Associated With Reimbursement of Medicines. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2026.08.006
van Hattem, C. C., Bloem, L. T., Reijnders, C. M. A., Janssens, G. E. P. J., Egberts, T. C. G., & Fabriek, B. O. (2026). Patient access to cell and gene therapies through the European hospital exemption pathway in the Netherlands. Cytotherapy, Article 103011. Advance online publication. https://doi.org/10.1016/j.jcyt.2026.103011
Bouwman, L., Almeida, D., Jonker, C., Leufkens, H., Sepodes, B., & Torre, C. (2026). Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025. Therapeutic Innovation and Regulatory Science. Advance online publication. https://doi.org/10.1007/s43441-026-01044-5
Coppes, T. (2026). Hydrate before you medicate: Implementation of sick day guidance in primary care. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/3644
van Dommelen, J. E. M., Gardarsdottir, H., Egberts, T. C. G., & Giezen, T. J. (2026). Drug exposure definitions reported in real-world evidence studies on oncology medicines in patients with colorectal cancer: a scoping review. ESMO Real World Data and Digital Oncology, 13, Article 100750. https://doi.org/10.1016/j.esmorw.2026.100750
Bakker, S., Baas, G., Bouvy, M. L., Denig, P., & Heringa, M. (2026). Implementation of a deprescribing guideline by community pharmacists: A focus group study. Exploratory Research in Clinical and Social Pharmacy, 23, Article 100813. https://doi.org/10.1016/j.rcsop.2026.100813
De Graef, M., Serraes, B., Heirman, J., Heerdink, E. R., Dilles, T., & Dijkstra, N. E. (2026). Pharmaceutical technical assistants on hospital wards: Qualitative interdisciplinary perspectives. Exploratory Research in Clinical and Social Pharmacy, 23, Article 100787. https://doi.org/10.1016/j.rcsop.2026.100787
Butrimaite, V., Blockyte, M., Kazlauskaite, J. A., Lasys, T., & Kubiliene, L. (2026). Primary Non-Adherence to Electronic Prescriptions in Lithuania, 2018–2024: Nationwide Prevalence, Factors, and Regional Variation. Pharmacoepidemiology, 5(3), Article 33. https://doi.org/10.3390/pharma5030033
Oskam, S. M. P., Bloem, L. T., Hoefnagel, M. H. N., Ehmann, F., Broeders, M., & Pasmooij, A. M. G. (2026). The platform technology approach in the EU regulation of medicines for human use: Stakeholder perspectives on its definition and implementation. Drug Discovery Today, 31(5), Article 104740. https://doi.org/10.1016/j.drudis.2026.104740
Essink, S. C. M., Joosse, I. R., Salcher-Konrad, M., Walter, M., Deligianni, E., Tsioumela, D., Kontogiorgis, C., Poplavska, E., Žīgure, I., Hoeve, C. E., Alves, T. L., van Vliet, E. D., Ferreira-da-Silva, R., Kodrič, A., Kos, M., Erviti, J., Gutiérrez-Valencia, M., Saiz, L. C., Sporrong, S. K., ... De Bruin, M. L. (2026). Implementation and use of risk minimization control tools in the EU: A multistakeholder survey. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70783
Mitra, M., Versteeg, J.-W., Schermer, M. D., Najafabadi, S. N., Bruin, M. L. D., & Bloem, L. T. (2026). Schema-Guided Hierarchical Information Extraction and Semantic Evaluation Using Generative AI. arXiv. https://doi.org/10.48550/arXiv.2608.06167
Liang, D., Weir, D. L., Thevasahayam, S., Deneer, V. H. M., Siebes, A., & Gardarsdottir, H. (2026). Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70733
Lutz, M., Moleman, T., & Leufkens, H. G. M. (2026). European science for health research needs and priorities. European Journal of Pharmaceutical Sciences, 223, Article 107570. https://doi.org/10.1016/j.ejps.2026.107570
Petro, E., Mantel-Teeuwisse, A. K., Joosse, I. R., Siebers, A. C. M., Suleman, F., & van den Ham, H. A. (2026). Access to essential medicines in Albania: a cross-sectional survey of availability, prices and affordability using the WHO/Health Action International (HAI) Global Core List. BMJ Open, 16(8), Article e121273. https://doi.org/10.1136/bmjopen-2026-121273
Lambert, M., Smit, C. C. H., Taxis, K., & Pont, L. (2026). Antibiotic Shortages: Pharmacists’ Experiences, Perspectives, and Perceived Clinical Impacts. Antibiotics, 15(8), Article 808. https://doi.org/10.3390/antibiotics15080808
de Ruijter-van Dalem, J., Janssen, M. J. A., Driessen, J. H. M., Siegert, C. E. H., Marmorale, A., Weir, D. L., & Karapinar-Çarkit, F. (2026). Incidence and duration of hospital-initiated opioids, benzodiazepines and antipsychotics: a retrospective cohort study. International Journal of Clinical Pharmacy, 48(4), 1694-1702. https://doi.org/10.1007/s11096-026-02152-w
Klerk-Bos, K. L., Hennus, M. P., Ehlert, M., Kluijtmans, M., Egberts, T. C. G., & Wilting, I. (2026). Learning, adopting, and sustaining the pharmacist-clinician role in clinical practice: a qualitative study among early adopters in the Netherlands. International Journal of Clinical Pharmacy, 48(4), 1672-1681. https://doi.org/10.1007/s11096-026-02150-y
Ross, S. B., Bortolussi-Courval, É., Juhásová, Z., Weir, D. L., Wilson, A. G., Lee, T. C., McDonald, E. G., & Wilson, M. G. (2026). Measuring Medication Related Harm: Proposed Guidance for Adverse Drug Event Adjudication to Harmonize Outcomes in Deprescribing Research. Journal of the American Geriatrics Society, 74(8), 2473-2479. https://doi.org/10.1111/jgs.70482
de Kleijn, L., Jansen-Groot Koerkamp, E. A. W., Chiarotto, A., Heringa, M., Rijkels-Otters, H. J. B. M., Blom, J. W., Numans, M. E., Bouvy, M. L., & Koes, B. W. (2026). Outcomes of an opioid reduction tool among patients with chronic noncancer pain in primary care. Family Practice, 43(4), Article cmag049. https://doi.org/10.1093/fampra/cmag049
Dutch-MSR consortium, Molenaar, P. C. G., Weir, D. L., Arnoldus, E. P. J., Beenakker, E. A. C., van den Bos, R. P. M., van Eijk, J. J. J., Feenstra, C., van Geel, B. M., Heersema, D. J., Hoitsma, E., Horvath, K. M., Killestein, J., Kragt, J. J., van Munster, C. E. P., Snoeijen, A. H. W. J. M., Wokke, B. H. A., Goettsch, W. G., Strijbis, E. M. M., ... de Jong, B. A. (2026). Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis. Multiple Sclerosis and Related Disorders, 112, Article 107268. https://doi.org/10.1016/j.msard.2026.107268
van Gelder, T. G., Lalmohamed, A., Egberts, T. C. G., Slooter, A. J. C., Zegers, M., van den Boogaard, M., & van Diem-Zaal, I. J. (2026). The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors. Journal of Critical Care, 94, Article 155558. https://doi.org/10.1016/j.jcrc.2026.155558
Engelhardt, E. G., Hackert, M. Q. N., Vogelaar, A., de Jong, A. F., Guerrero Paez, C., van der Velden, A. W. G., Putker, C., Agterof, M. J., van de Garde, E. M. W., & van Uden-Kraan, C. F. (2026). An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation. JMIR Cancer, 12, Article e73156. https://doi.org/10.2196/73156
de Sévaux, J. L., Lalmohamed, A., Damoiseaux, R. A., Schilder, A. G., Souverein, P. C., Hay, A. D., & Venekamp, R. P. (2026). COVID-19 impact on otitis media consultations and antibiotic use in general practice. BJGP Open. Advance online publication. https://doi.org/10.3399/BJGPO.2026.0009
Costa, E., Girotti, S., Elayan, S., Castellani, C., Cavaller Bellaubi, M., Goettsch, W., Radulović, M., Rocha, J., Russo, P., Simoens, S., & Leopold, C. (2026). Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries. Journal of Cystic Fibrosis. Advance online publication. https://doi.org/10.1016/j.jcf.2026.07.008
Roji, M. D., Geiselhardt, F., Beythien, G., Laudeley, K., Mirolo, M., Jo, W. K., Martino, L., Beineke, A., Baumgärtner, W., Peters, M., van den Brand, J. M. A., Jensen, T. H., Kuiken, T., Langedijk, J. P. M., Domingo, M., Osterhaus, A. D. M. E., & Ludlow, M. (2026). Human and animal morbillivirus strains causing chronic neurological infections share key genotypic and phenotypic traits. Proceedings of the National Academy of Sciences of the United States of America, 123(28), Article e2604205123. https://doi.org/10.1073/pnas.2604205123
Trang, T. P. H., Bazelier, M. T., Klungel, O. H., & Bots, S. H. (2026). Quality and methodological heterogeneity of COVID-19 vaccine safety studies focusing on the myocarditis safety signal: A systematic review, meta-analysis and meta-regression. Vaccine, 85, Article 128722. https://doi.org/10.1016/j.vaccine.2026.128722
Murciano-Gamborino, C., Pérez-Breva, L., de Jong, A. J., Boeckhout, M., van Thiel, G. J. M. W., Huntley, K., Traore, H., Gardarsdottir, H., & Fons-Martinez, J. (2026). Addressing the Key Challenges of Decentralized Clinical Trials in Europe: Multistakeholder Perspective Delphi Study. Journal of Medical Internet Research, 28, Article e80625. https://doi.org/10.2196/80625
Baas, G., Heringa, M., Verdoorn, S., Kwint, H.-F., Badawy, E., Gussekloo, J., Burgers, J., Denig, P., & Bouvy, M. L. (2026). Deprescribing in older patients with hyperpolypharmacy: a cluster-randomised trial in primary care. Age and Ageing, 55(7), Article afag209. https://doi.org/10.1093/ageing/afag209
Nollen, L. M., van Westen, G. J. P., Westman, G., & Pasmooij, A. M. G. (2026). Artificial Intelligence for Regulatory Evidence: A Systematic Document Analysis of European Medicines Agency Regulatory Advice and Public Reports. Clinical Pharmacology and Therapeutics, 120(1), 224-235. https://doi.org/10.1002/cpt.70300
Arguedas, D., Bui, V., Law, T., Rijmers, J., Tissier, R., Beijnen, J. H., van Tellingen, O., Lebre, M. C., & Schinkel, A. H. (2026). Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue. Pharmacological Research, 229, 1-14. Article 108226. https://doi.org/10.1016/j.phrs.2026.108226
van Veldhuisen, D. J., Rienstra, M., Mosterd, A., Alings, M., Voors, A. A., Damman, K., van Asselt, A. D. I., Bouvy, M. L., Schaap, J., van der Wall, E. E., Crijns, H. J. G. M., Touw, D. J., Hoogslag, P. A. M., van de Swaluw, J. E. C., Schuurman, R. J., van der Sluis, A., Bondarenko, O., Römer, T. J., Oosterhof, T., ... van der Meer, P. (2026). Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial. Nature Medicine, 32(7), 2647-2653. https://doi.org/10.1038/s41591-026-04406-6
Ochi, T., den Uil, M. G., Piazza, G., Frederix, G. W. J., Hak, E., Deneer, V. H. M., & Feenstra, T. L. (2026). Cost-effectiveness of pre-emptive pharmacogenetic testing: An umbrella review. PloS one, 21(6), 1-18. Article e0338277. https://doi.org/10.1371/journal.pone.0338277
De Graef, M., Heirman, J., Snoeck, T., Heerdink, E. R., Dijkstra, N. E., Dilles, T., & Serraes, B. (2026). Roles and impact of pharmacy technicians on hospital wards: a systematic review. International Journal of Nursing Studies Advances, 11, Article 100593. Advance online publication. https://doi.org/10.1016/j.ijnsa.2026.100593
Verschueren, M. V. (2026). Real-world outcomes of immunotherapy
in lung cancer patients: Prompt evidence generation beyond clinical trials. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/3435
Stock, C., Duijndam, B., Siezen, C. L. E., & Pasmooij, A. M. G. (2026). Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory Perspective. Nucleic Acid Therapeutics, 36(3), 135-146. https://doi.org/10.1177/21593337261429852
Kashmour, S., Kempen, T. G. H., Boussaboun, Y., & Gemmeke, M. (2026). Women's perspectives on acute cystitis care and the role of the community pharmacy: a qualitative study. SSM - Qualitative Research in Health, 9, Article 100727. https://doi.org/10.1016/j.ssmqr.2026.100727
CONSIGN Collaboration Group, de Bruin, O., Maisonneuve, E., Hurley, E., Nordeng, H. M. E., Bérard, A., Sheehy, O., Kaul, P., Shinde, M. U., Cosgrove, A., Lyons, J. G., Messenger-Jones, E., Kempner, M. E., Toh, S., Hua, W., Hernández-Muñoz, J. J., Sahin, L., Cesta, C. E., Hägg, D., ... Sturkenboom, M. C. J. M. (2026). Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North America. International Journal of Gynecology and Obstetrics, 173(3), 1197-1206. https://doi.org/10.1002/ijgo.70694
Boer-de Boer, M., de Roock, S., Egberts, T. C. G., Lalmohamed, A., & Swart, J. F. (2026). Changes in systemic medication in children and adolescents with JIA: why, when and which patterns. Rheumatology, 65(6), Article keag296. https://doi.org/10.1093/rheumatology/keag296
Hunt, N. B., Souverein, P., Bazelier, M., Barclay, N., Delmestri, A., Sturkenboom, M., Prieto-Alhambra, D., Gardarsdottir, H., & Klungel, O. (2026). Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use. Clinical Pharmacology and Therapeutics, 119(6), 1574-1583. https://doi.org/10.1002/cpt.70242
Grupstra, R. J., Starokozhko, V., Bakker, E., Pasmooij, A. M. G., & Mol, P. G. M. (2026). More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations. Clinical Pharmacology and Therapeutics, 119(6), 1522-1536. https://doi.org/10.1002/cpt.70229
Lifelines Corona Research Initiative (2026). Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case–Control Study. Pharmaceuticals, 19(6), Article 861. https://doi.org/10.3390/ph19060861
Mertens - Stutterheim, J., & Kempen, T. (2026). Voorschrijven door apothekers: van informele praktijk naar formele rol. Web publication/site, Nieuwsbrief Zorg en Innovatie. http://nieuwsbriefzorgeninnovatie.nl/voorschrijven-door-apothekers-van-informele-praktijk-naar-formele-rol/
Mtei, M., Hien Trang, T. P., Navarro-Torné, A., Douglas, I. J., & Schultze, A. (2026). Approaches to observational study designs and analytical options to evaluate the safety of multi-dose vaccines: a systematic review. Expert Review of Vaccines, 25(1), Article 2667740. https://doi.org/10.1080/14760584.2026.2667740
Lewis, O. C., Leopold, C., Hoek, J. M., Schiffelers, R. M., & De Bruin, M. L. (2026). Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70577
Joosse, I. R., Doblas Rodriguez de Guzman, L., Mantel-Teeuwisse, A. K., & Van Den Ham, H. A. (2026). A controversial change in the sustainable development goal indicator for access to medicines. Bulletin of the World Health Organization, 104(8), 579-581. https://doi.org/10.2471/BLT.25.294862
Brouwers, J. R., Tillemans, M. P. H., Muris, J. W., & Egberts, TCG. (2026). Intranasaal vitamine B12 in Nederland onderbelicht: Goed alternatief voor orale en intramusculaire toediening. Pharmaceutisch Weekblad, 161(18), 14-17. https://www.pw.nl/nieuws/achtergrondartikel/2026-05/intranasaal-vitamine-b12-nederland-onderbelicht
Kempen, T. G. H., Fayzi, Z., & Mertens, J. F. (2026). Competencies needed for pharmacist prescribing: A qualitative study of competency frameworks to identify gaps in Dutch pharmacy education. Currents in Pharmacy Teaching and Learning, 18(5), Article 102589. https://doi.org/10.1016/j.cptl.2026.102589
ten Hoope, S. M. K., Marongiu, S., Siegert, C. E. H., Heerdink, E. R., Janssen, M. J. A., & Karapinar-Çarkit, F. (2026). Conducting Medication Reviews: A Comparative Study Between ChatGPT-4 and Healthcare Professionals. Journal of the American Geriatrics Society, 74(5), 1378-1385. https://doi.org/10.1111/jgs.70415
Essink, S. C. M., Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Zomerdijk, I. M., Groenwold, R. H. H., Saliete, I., Poplavska, E., Kurvits, K., De Bruin, M. L., & Gardarsdottir, H. (2026). Dispensing of benzodiazepines and benzodiazepine-related drugs in Estonia, Latvia and Lithuania: a cross-national drug utilisation study. Nordic Journal of Psychiatry, 80(4), 265-276. https://doi.org/10.1080/08039488.2026.2671998
Falke, C. M., Koolen, M. F. J., Timmer, S. L., Karapinar-Çarkit, F., Bouvy, M. L., Egberts, A. C. G., & Knol, W. (2026). Perspectives of Older Patients on the Complexity of Medication Use. Journal of the American Geriatrics Society, 74(5), 1255-1264. https://doi.org/10.1111/jgs.70311
Hoek, J. M., Broeders, M., Hernandez, J. F., Main, H., Meij, P., Warmerdam, D. O., Bloem, L. T., Ten Ham, R. M. T., & RSNN SIG Advanced Therapies Steering Committee (2026). Shaping national networks to improve patient access to advanced therapy medicinal products in Europe. Drug Discovery Today, 31(3), Article 104661. https://doi.org/10.1016/j.drudis.2026.104661
Bloem, L. T., Fabriek, B. O., Schiel, A., & ten Ham, R. M. T. (2026). Regulatory and Health Technology Assessment of ATMPs in the European Union: Towards Patient Access. In A. C. Silva (Ed.), Springer Handbook of Medical Biotechnology (pp. 681-712). (Springer Handbooks; Vol. Part F1789). Springer Nature Switzerland. https://doi.org/10.1007/978-3-032-01636-2_30
Ogar, C. K., Sisay, M. M., Roque-Pereira, L., Leopold, C., Souverein, P. C., Mantel-Teeuwisse, A. K., & De Bruin, M. L. (2026). Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70580
Versteeg, J.-W., Bruin, M. D., Schermer, M., Najafabadi, S. N., Mitra, M., Leopold, C., Mantel-Teeuwisse, A., Goettsch, W., & Bloem, L. T. (2026). Text Mining Methods for Automated Data Extraction from Health Technology Assessment Reports of Medicines Using Classical Natural Language Processing and Generative Artificial Intelligence. JAMIA Open, 9(2), Article ooag051. https://doi.org/10.1093/jamiaopen/ooag051
HTx Study Group, Németh, B., Delnoij, D., Knies, S., Tachkov, K., Milushewa, P., Mitkova, Z., Goettsch, W., Liu, L., & Kaló, Z. (2027). Transferability of Patient Selection Model for Proton Radiation Therapy to Lower-Income European Countries. Value in Health Regional Issues, 57, Article 101628. Advance online publication. https://doi.org/10.1016/j.vhri.2026.101628
Kempen, T. G. H., Gemmeke, M., Bijlsma, E. Y., Egberts, T. C. G., Philbert, D., & Bouvy, M. L. (2026). Integration of pharmacy practice research in the Dutch pharmacy education continuum. International Journal of Pharmacy Practice, Article riag053. Advance online publication. https://doi.org/10.1093/ijpp/riag053
Petro, E., Hart, R. P. M., Mantel-Teeuwisse, A. K., van den Ham, H. A., Suleman, F., & Joosse, I. R. (2026). Access to child-appropriate medicines in community pharmacies in Albania: a cross-sectional survey using SDG indicator 3.b.3. BMJ Open, 16(4), e113798. Article e113798. https://doi.org/10.1136/bmjopen-2025-113798
Coppes, T., Koster, E. S., Philbert, D., van Gelder, T., & Bouvy, M. L. (2026). ESCP best practice: development, implementation and evaluation of sick day guidance in primary care in the Netherlands. International Journal of Clinical Pharmacy, 48(2), 667-676. https://doi.org/10.1007/s11096-026-02097-0
Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., van Steenbergen, L. N., Dahan, A., Rosendaal, F. R., & Gademan, M. G. J. (2026). Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study. Pharmacoepidemiology and Drug Safety, 35(4), Article e70368. https://doi.org/10.1002/pds.70368
Ljungdahl, N., Kälvemark-Sporrong, S., Tranberg, A., & Kempen, T. (2026). Pharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study. International Journal of Clinical Pharmacy, 48(2), 501-512. https://doi.org/10.1007/s11096-025-02006-x
Lasys, T. (2026). Assessing Impact of Pharmacovigilance Interventions in Europe: Methods and Applications. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/3352
Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., van Steenbergen, L. N., Dahan, A., Rosendaal, F. R., & Gademan, M. G. J. (2026). Association of benzodiazepine and opioid use with hip fracture treated with arthroplasty: a nationwide case-control study. BMC Geriatrics, 26(1), Article 361. https://doi.org/10.1186/s12877-025-06803-x
Gómez-Coronado-Martín, R., Salinero-Fort, M. Á., López-de-Andrés, A., Weir, D. L., & de Burgos-Lunar, C. (2026). Clinical Validation of Type 1 Diabetes Coding in Hospital Discharge Records Using ADA Criteria: Implications for Spanish and European Health Data Spaces. Journal of Clinical Medicine, 15(6), Article 2286. https://doi.org/10.3390/jcm15062286
Murciano-Gamborino, C., Pérez-Breva, L., de Jong, A. J., van Thiel, G., Santa-Ana-Tellez, Y., Boeckhout, M., Siiskonen, S. J., van Rijssel, T., Gardarsdottir, H., & Fons-Martinez, J. (2026). SWOT analysis of decentralised clinical trials from an ethical, legal, regulatory and operational perspective. BMC Medical Ethics, 27(1), Article 57. https://doi.org/10.1186/s12910-026-01391-w
DECISION Investigators, van der Meer, P., Voordes, G. H. D., Vijver, M. A. T., Mosterd, A., Alings, A. M., Maas-Soer, E. L., de Vos, A. H., Schut, A., van Asselt, A. D., Bouvy, M. L., Tijssen, J. G. P., Damman, K., Schaap, J., van der Wall, E. E., Voors, A. A., Crijns, H. J., Lok, D. J., Westendorp, I. C., ... van Veldhuisen, D. J. (2026). Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial. European Journal of Heart Failure. Advance online publication. https://doi.org/10.1093/ejhf/xuag073
Kan, I., Vander Kloet, M. A., Lein, R. K., Koehler, T., Blokzijl, M. R., Mantel-Teeuwisse, A. K., & Alfarah, M. (2026). Equity, Diversity, Inclusion and Accessibility in pharmacy education: a scoping review protocol. BMJ Open, 16(3), Article e111778. https://doi.org/10.1136/bmjopen-2025-111778
Moslemzadeh, D., Souverein, P. C., Belitser, S. V., Heerdink, E. R., Klungel, O. H., & Abtahi, S. (2026). Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study. Pharmacoepidemiology and Drug Safety, 35(3), Article e70343. https://doi.org/10.1002/pds.70343
Nguyen, K. H. M., Abadier, M., Hazen, A. C. M., Heringa, M., Kwint, H.-F., van Dijk, L., Bouvy, M. L., & Kempen, T. G. H. (2026). Prescription modifications by pharmacists and their views on potential prescribing authority: a nationwide survey. The International Journal of Pharmacy Practice. Advance online publication. https://doi.org/10.1093/ijpp/riag031
Jordan, R. E., Keene, S. J., Franssen, F. M. E., Fitzmaurice, D., Adderley, N. J., Dickens, A. P., Martin, J. T., Sitch, A. J., Enocson, A., Jowett, S., Riley, R. D., Miller, M. R., Cooper, B. G., Turner, A., Jolly, K., Ayres, J. G., Stockley, R., Greenfield, S., Siebert, S., ... Adab, P. (2026). Prognostic score for predicting respiratory admissions among patients with chronic obstructive pulmonary disease in primary care: development and validation in population cohorts (Birmingham Lung Improvement Studies (BLISS)). BMJ (Clinical research ed.), 392, e084521. https://doi.org/10.1136/bmj-2025-084521
Versteeg, J.-W., Goettsch, W. G., Mantel-Teeuwisse, A. K., Ollendorf, D., & Leopold, C. (2026). A multi-stakeholder survey on communicating cost-effectiveness uncertainties to stakeholders: a case study of ICER. Health Affairs, 4(3), Article qxag009. https://doi.org/10.1093/haschl/qxag009
Kleine Schaars, K., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H. J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., Deneer, V. H. M., & van Westrhenen, R. (2026). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants. European Journal of Human Genetics, 34(3), 379-386. https://doi.org/10.1038/s41431-025-02008-3
Gemmeke, M., Jansen, M. C., Kempen, T. G. H., & Bouvy, M. L. (2026). Healthcare providers' perspectives on collaboration of care for acute cystitis in women and the role of the community pharmacy: A qualitative study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100694. https://doi.org/10.1016/j.rcsop.2025.100694
Falke, C., Karapinar-Carkit, F., Knol, W., Bouvy, M., Egberts, T., Kempen, T., Vervloet, M., & Heringa, M. (2026). Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100692. https://doi.org/10.1016/j.rcsop.2025.100692
Mohmaed Ali, M. I., van der Heijden, L. T., Tibben, M., Rosing, H., Kalicharan, R., Ruiter, G., Beijnen, J. H., Huisman-siebinga, H., Huitema, A. D. R., & Steeghs, N. (2026). Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib. Clinical Pharmacology & Therapeutics, 119(3), 713-720. https://doi.org/10.1002/cpt.70141
Tonn, M., Bognàr, T., Kupka, R., Wilting, I., Nederlof, M., Egberts, T., & Lalmohamed, A. (2026). The Effect of COVID-19 Pandemic Restrictions on Laboratory Monitoring of Lithium Treated Outpatients in the Netherlands: A Controlled Interrupted Time Series Analysis. Pharmacoepidemiology and Drug Safety, 35(3), Article e70349. https://doi.org/10.1002/pds.70349
Rosenberg, N., Hollak, C. E. M., Haverhoek, V. A., Stoyanova-Beninska, V., Pasmooij, A. M. G., & de Visser, S. J. (2026). Tracing the path of non-industry-driven medicine development for rare diseases through regulatory interactions at the European Medicines Agency. Drug Discovery Today, 31(2), Article 104631. https://doi.org/10.1016/j.drudis.2026.104631
Hazen, A., Kempen, T., Leendertse, A., Bouvy, M., van Dijk, L., & Zwart, D. (2026). Patients' Perspectives on the Role of General Practice-Based Pharmacists: A Focus Group Study. Patient Preference and Adherence, 20, Article 565194. https://doi.org/10.2147/PPA.S565194
Riera-Arnau, J., Paoletti, O., Gini, R., Thurin, N. H., Souverein, P. C., Abtahi, S., Durán, C., Pajouheshnia, R., & Roberto, G. (2026). Standardisation of terminology, calculation and reporting for assigning exposure duration to drug utilisation records from healthcare data sources: the CreateDoT framework. medRxiv. https://doi.org/10.64898/2026.02.18.26346576
Petro, E., van den Ham, H. A., Mantel-Teeuwisse, A. K., Martopullo, H., Joosse, I. R., & Suleman, F. (2026). Access to pediatric medicines in Albania: A qualitative study of family doctors’ perceptions. PLOS Global Public Health, 6(2), Article e0005861. https://doi.org/10.1371/journal.pgph.0005861
van de Burgt, B. W. M., van Dijck, L. F. C., Dullemond, B., Jessurun, N. T., van Seyen, M., van Marum, R. J., van Wensen, R. J. A., Liu, W. Y., van der Linden, C. M. J., Grouls, R. J. E., Bouwman, R. A., Korsten, E. H. M., & Egberts, T. C. G. (2026). Portability of a text mining algorithm for detecting adverse drug reactions in electronic health records across diverse patient groups in two Dutch hospitals. PLOS Digital Health, 5(2), Article e0001230. https://doi.org/10.1371/journal.pdig.0001230
Galli, M., Pereira, N. L., Lennon, R. J., van den Broek, W. W. A., Claassens, D. M. F., Bergmeijer, T. O., Rosenberg, Y., Fazzini, L., Deneer, V. H. M., Murad, M. H., Farkouh, M. E., Rihal, C., ten Berg, J., & Angiolillo, D. J. (2026). Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC: Cardiovascular Interventions, 19(3), 283-296. https://doi.org/10.1016/j.jcin.2025.11.029
Bouwman, L., Leufkens, H., Sepodes, B., & Torre, C. (2026). Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023. PloS one, 21(2), Article e0342698. https://doi.org/10.1371/journal.pone.0342698
Lasys, T., Essink, S. C. M., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Zomerdijk, I. M., Groenwold, R. H. H., Bruin, M. L. D., & Gardarsdottir, H. (2026). Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis. European Journal of Clinical Pharmacology, 82(3), Article 68. https://doi.org/10.1007/s00228-025-03992-7
Eskola, S. M., Gigov, A., Leufkens, H. G. M., Bate, A., De Bruin, M. L., & Gardarsdottir, H. (2026). Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70471
Baas, G., Heringa, M., Verdoorn, S., Kwint, H.-F., Badawy, E., Gussekloo, J., & Bouvy, M. (2026). A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed-Methods Feasibility Study. Basic & Clinical Pharmacology & Toxicology, 138(2), Article e70184. https://doi.org/10.1111/bcpt.70184
van Dijk, E. J., Smeenk, M. M., Bensch, F., Sadowksa, A. M., Verschueren, M. V., Verhaert, M., Llobell, A., Suzuki, Y., Liew, D. F. L., Takeji, A., Maria, A. T. J., Peters, B. J. M., Garcia Morillo, J. S., Chatzidionysiou, K., Lidar, M., van der Hout, E. C., Aspeslagh, S., Herder, G. J. M., van de Garde, E. M. W., ... Verheijden, R. J. (2026). Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer. ESMO Open, 11(2), Article 106052. https://doi.org/10.1016/j.esmoop.2025.106052
Zhang, X. Y. C., Scott, E. N., Maagdenberg, H., Man, A., Li, K. H., Rassekh, S. R., Carleton, B. C., Ross, C. J. D., Wasserman, W. W., & Loucks, C. M. (2026). Pathway-Informed Machine Learning Identifies Genetic Predictors of High-Dose Methotrexate-Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia. Clinical Pharmacology & Therapeutics, 119(2), 447-456. https://doi.org/10.1002/cpt.70135
Kaló, Z., Petrova, G., Németh, B., Bonča, P. D., Delnoij, D., Bennett, A., Tachkov, K., Zhang, Y., Kreif, N., Knies, S., Lipska, I., Tesar, T., Mitkova, Z., Ponten, J., Viberg, A., Paveliu, M. S., Piniazkho, O., Turcu-Stiolica, A., Doležal, T., ... Manca, A. (2026). Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. Health Science Reports, 9(2), Article e71534. https://doi.org/10.1002/hsr2.71534
Delnoij, D. M. J., Dawoud, D. M., Elvidge, J., Kaló, Z., Knies, S., Németh, B., & Goettsch, W. (2026). Innovating HTA: a call for capacity building and standardization. International Journal of Technology Assessment in Health Care, 42(1), Article e8. https://doi.org/10.1017/S0266462326103456
de Booij, G., Besselsen, S., Philbert, D., Bouvy, M., Haeck, I. M., van Tuyll van Serooskerken, A.-M., & Gemmeke, M. (2026). Waardering voor nieuwe uitlegkaart, gids en smeerplan over eczeem: Kleinschalig onderzoek onder patiënten en zorgverleners over informatiematerialen. Pharmaceutisch Weekblad, 161(4), 20-22. https://www.pw.nl/achtergrond/waardering-voor-nieuwe-uitlegkaart-gids-en-smeerplan-over-eczeem
Leopold, C., Huisman, A. H., Vlaar, K. J. G. M., Bloemendal, H. J., & Barjesteh van Waalwijk van Doorn-Khosrovani, S. (2026). Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the Netherlands. Acta Oncologica, 65, 22-31. https://doi.org/10.2340/1651-226X.2026.45000, https://doi.org/10.2340/1651-226X.2026.45000
Harding, E., de Fouw, C., Bouvy, M. L., van Woerkom, M., & van der Ende, M. Y. (2026). Therapietrouw. Nederlands Tijdschrift voor Geneeskunde, 170, Article D8823. https://www.ntvg.nl/artikelen/therapietrouw-0
CONSIGN Collaboration Group, de Bruin, O., Maisonneuve, E., Hurley, E., Nordeng, H. M. E., Bérard, A., Sheehy, O., Kaul, P., Shinde, M. U., Cosgrove, A., Lyons, J. G., Messenger-Jones, E., Kempner, M. E., Toh, S., Hua, W., Hernández-Muñoz, J. J., Sahin, L., Cesta, C. E., Hägg, D., ... Sturkenboom, M. C. J. M. (2026). Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North America. Pharmacoepidemiology and Drug Safety, 35(1), Article e70303. https://doi.org/10.1002/pds.70303
Kruithof, P. D., Souverein, P. C., Driessen, J. H. M., Hendriks, L. E. L., Croes, S., & van Geel, R. M. J. M. (2026). Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry Data. Pharmacoepidemiology and Drug Safety, 35(1), Article e70299. https://doi.org/10.1002/pds.70299
van der Zee, I. T., Hoek, J. M., Hoekman, J., & De Bruin, M. L. (2026). Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literature. Drug Discovery Today, 31(1), Article 104597. https://doi.org/10.1016/j.drudis.2026.104597
Lambert, M., Mmassy, J., Kabissi, S., Benizeth, C., Baltazary, G., Maganda, B. A., & Taxis, K. (2026). Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting. International Health, 18(1), 1-4. https://doi.org/10.1093/inthealth/ihaf079
Fragoulakis, V., Swen, J. J., Koufaki, M. I., Blagec, K., Blagus, T., Böhringer, S., Cambon-Thomsen, A., Cecchin, E., Cheung, K. C., Deneer, V. H. M., Dupui, M., Jonsson, S., Joefield-Roka, C., Just, K. S., Karlsson, M. O., Konta, L., Koopmann, R., Kriek, M., Lehr, T., ... Mitropoulou, C. (2026). Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study. EClinicalMedicine, 91, Article 103686. https://doi.org/10.1016/j.eclinm.2025.103686
Adhien, P. (2026). NEDERLAND MOET ZICH AANSLUITEN BIJ EUROPA INZAKE BEHANDELING OBESITAS:HANTEREN VAN VERSCHILLENDE RICHTLIJNEN IS VERWARREND EN ACHTERHAALD. Pharmaceutisch Weekblad, 161(5), 32-33.
Rijke, N., Yamout, B. I., Saylor, D., Nonino, F., Filippini, G., Piggott, T., Laurson-Doube, J., Amato, L., Banerjee, T. K., Costello, K., Giovane, C. D., De Stefano, N., Abkari, N. E., Giovannoni, G., Hartung, H. P., Helme, A., Mantel-Teeuwisse, A., Prato Chichiraldi, A., Ali Sahraian, M., ... Schünemann, H. (2026). Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings. Multiple Sclerosis and Related Disorders, 105, Article 106878. https://doi.org/10.1016/j.msard.2025.106878
Lambert, M., Aljadeeah, S., Nasir, N., Sila, F., Lopes, L., & Llor, C. (2026). Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices. The Lancet Primary Care, 2(1), Article 100084. https://doi.org/10.1016/j.lanprc.2025.100084
Coenen, M. J. H., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & van Schaik, R. H. N. (2026). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines. European Journal of Human Genetics, 34(1), 152–160. https://doi.org/10.1038/s41431-025-01986-8
Moleman, T., Mantel-Teeuwisse, A. K., Ravinetto, R., Suleman, F., Lates, J., & Aljadeeah, S. (2026). Exploring pharmaceutical waste management in Southern Africa: a scoping review. Journal of Pharmaceutical Policy and Practice, 19(1), Article 2700215. https://doi.org/10.1080/20523211.2026.2700215
van de Voort, T. W., Hoekman, J., Moors, E. H. M., & Bloem, L. T. (2026). Five decades of gene therapy innovation and regulation in the US and EU: A historical analysis. Molecular Therapy. Advance online publication. https://doi.org/10.1016/j.ymthe.2026.10.009
Sadreghaemy, M., Boon, W., Heerdink, E. R., Egberts, T. C. G., & Bloem, L. T. (2026). From donation to redispensing of medicines: an event analysis of medicine reuse in the Netherlands. SSRN working paper. https://doi.org/10.2139/ssrn.6532331
Heesbeen, E. J., Souverein, P. C., Heerdink, E. R., Bijlsma, E. Y., & Groenink, L. (2026). Glucocorticoid exposure and initiation of SSRIs among patients with rheumatoid arthritis: A nested case–control study in UK primary care. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1002/bcp.70726
Richardson, M., Augustovski, F., Pegg, M., Seck, C., Kar, S. S., & Goettsch, W. (2026). Next Generation Methods in Health Technology Assessment (HTA): Need, Rigor, and Implementability. International Journal of Technology Assessment in Health Care, 42(1), Article e58. https://doi.org/10.1017/S0266462326103900
Tweel, A. C. V. D., Bouvy, M., Veldkamp, N., van Hoften, C., Star, M., Hoogland, P., & Gemmeke, M. (2026). Patiënten waarderen digitale begeleiding bij medicijnzalf: database- en vragenlijstondrzoek naar tips in de service aptoheek-app. Pharmaceutisch Weekblad, 161(24), 18-21.
Annema, P. A., Venrooij, L. M. W. N., Bouvy, M. L., van Marum, R. J., & Derijks, H. J. (2026). Patient perspectives on drug recalls in the Netherlands: a qualitative study. International Journal of Clinical Pharmacy, 48(3), 864-873. https://doi.org/10.1007/s11096-025-02082-z
Beravs-Bervar, K., Goettsch, W., Gutierrez-Ibarluzea, I., Skali, A., Rűther, A., Lipska, I., & Turk, E. (2026). Strengthening Health Technology Assessment (HTA) in the European Union: Insights from Slovenia's Implementation Journey. International Journal of Technology Assessment in Health Care, 42(1), Article e23. https://doi.org/10.1017/S0266462325103383
Svensson, A., Ljungvall, H., Kempen, T., Kälvemark-Sporrong, S., & Peterson, M. (2026). The constant conflicts of opioid prescribing–GPs’ views on treating chronic pain with opioids in primary care: a reflexive qualitative analysis. Scandinavian Journal of Primary Health Care, 44(1), Article 2665697. https://doi.org/10.1080/02813432.2026.2665697
2025
Maisonneuve, E., Luxi, N., Bellitto, C., Ciccimarra, F., Raethke, M., van Hunsel, F., Lieber, T., Mulder, E., Riefolo, F., Villalobos, F., Thurin, N. H., Batel-Marques, F., Morton, K., O'Shaughnessy, F., Cleary, B., Sonderlichová, S., Farcas, A., Bucsa, C., Favre, G., ... Panchaud, A. (2025). Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women. Frontiers in Drug Safety and Regulation, 5, Article 1689349. https://doi.org/10.3389/fdsfr.2025.1689349
Cooijmans, S., Engelen, E. M. C., Wuyts, S. C. M., Kramers, C., van Agtmael, M. A., van den Bemt, P. M. L. A., Bouvy, M. L., Amouch, H., Autar, R. S., Benoist, G. E., van Berlo-van de Laar, I. R. F., Derijks-Engwegen, J. Y. M. N., van den Elsen, G., Engelaer, F. M., Gombert-Handoko, K. B., Jansen, D. R. M., Kerskes, M. H. M., Kruik-Kollöffel, W. J., Kuijvenhoven, M. A., ... Knol, W. (2025). Less Is More: Optimized pharmacotherapy with improved coNtinuity of CarE in hospitaLized oLder peOple (LIMONCELLO): study protocol of a cluster randomized controlled trial. BMC Geriatrics, 25(1), Article 1034. https://doi.org/10.1186/s12877-025-06533-0
Van Gelder, T. G., Vergoossen, D., Zonnenberg, I. A., Lalmohamed, A., Koole-Oostveen, M. I., van Reij, E. M. L., van Loon, A., & Egberts, T. C. G. (2025). Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit. European Journal of Hospital Pharmacy, 33(1), 73-79. https://doi.org/10.1136/ejhpharm-2024-004300
Verschueren, M. V., Verschueren, D. V., van de Garde, E. M. W., & Bloem, L. T. (2025). A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients. CPT: Pharmacometrics and Systems Pharmacology, 14(12), 2006-2013. https://doi.org/10.1002/psp4.70075
Bognar, T. T., Garcia, M. M., Lalmohamed, A. A., Gungor, T. T., Hauri-Hohl, M. M., Prockop, S. S., Oram, L. L., Pai, S.-Y. S., Brooks, J. J., Savic, R. M. R., Dvorak, C. C. C., Long-Boyle, J. R. J., Krajinovic, M. M., Bittencourt, H. H., Teyssier, A. C. A.-C., Theoret, Y. Y., Martinez, C. C., Egberts, A. C. G. T., Morales, E. E., ... Bartelink, I. H. I. (2025). Association of Busulfan Exposure and Outcomes After Hematopoietic Cell Transplantation for Patients With an Inborn Error of Immunity. Therapeutic Drug Monitoring, 47(6).
Petro, E., Martopullo, T., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). 'Challenges in pediatric medicine access in Albania: insights from community Pharmacists'. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2521425. https://doi.org/10.1080/20523211.2025.2521425
Su, L., Chen, L., Betigeri, S., Dreyer, N., Gardarsdottir, H., Hendricks-Sturrup, R., & Burcu, M. (2025). Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real-World Data Utilization. Clinical Pharmacology and Therapeutics, 118(6), 1350-1365. https://doi.org/10.1002/cpt.70033
Arnamo, A. H., Pluim, D., Huitema, A. D. R., Jacobs, B. A. W., Beijnen, J. H., & Nuijen, B. (2025). Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials. Journal of Oncology Pharmacy Practice, 31(8), 1199-1209. https://doi.org/10.1177/10781552241279018
Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(12), 1873-1874. https://doi.org/10.1007/s00228-025-03917-4
Lambert, M., van Dijk, L., Benko, R., Llor, C., Lykkegaard, J., Mantel-Teeuwisse, A. K., Pont, L., & Taxis, K. (2025). The role of the community pharmacist in antibiotic use – a commentary on current status and future perspectives. Exploratory Research in Clinical and Social Pharmacy, 20, Article 100652. https://doi.org/10.1016/j.rcsop.2025.100652
Petro, E., Joosse, I. R., Siebers, A. C. M., Martopullo, T., Hart, R. P. M., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2025). Time and cost involved in measuring access to medicines: the case of Albania. BMC Research Notes, 18(1), Article 104. https://doi.org/10.1186/s13104-025-07168-5
Joosse, I. R., Mantel-Teeuwisse, A., Van den Ham, H. A., & Cantarero Arevalo, L. (2025). Availability of essential medicines for non-communicable diseases: a scoping review of challenges and opportunities. BMJ Global Health, 10(11), Article e019634. https://doi.org/10.1136/bmjgh-2025-019634
Van Brug, H. E., Nelissen, R. G. H. H., Rosendaal, F. R., Van Steenbergen, L. N., Bouvy, M. L., Dahan, A., & Gademan, M. (2025). Association of preoperative chronic opioid use with 1-year revision rate, mortality, and patient-reported outcomes after primary hip and knee arthroplasty: age, sex and BMI matter - a Dutch register-based study. Acta Orthopaedica, 96, 857-866. https://doi.org/10.2340/17453674.2025.44597
Versteeg, J.-W., Stam, N., Mantel-Teeuwisse, A. K., Timmers, L., Goettsch, W., & Leopold, C. (2025). Coverage With Evidence Development For Medicines with Insufficient Evidence Of Clinical Benefit: Experience From The Netherlands. International Journal of Technology Assessment in Health Care, 41(1), Article e83. https://doi.org/10.1017/S0266462325103267
van Vliet, E. D., Buhl, C., Jacobsen, R., Andersen, A., Almarsdóttir, A. B., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Kos, M., Čebron Lipovec, N., Ribeiro-Vaz, I., Silva, A. M., Ferreira, P., Poplavska, E., Abtahi, S., Hegger, I., & Leonardo Alves, T. (2025). Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2576620. https://doi.org/10.1080/20523211.2025.2576620
Rosenberg, N., Post, H. C., Schutte, T., de Visser, S. J., Bartelink, I., Pasmooij, A. M. G., van Laarhoven, H. W. M., & Hollak, C. E. M. (2025). Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries. ESMO Open, 10(11), Article 105855. https://doi.org/10.1016/j.esmoop.2025.105855
Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2025). Barriers and facilitators for effective sick day guidance implementation. Journal of Nephrology, 38(8), 2463-2467. https://doi.org/10.1007/s40620-025-02396-1